Maria Laura Fox

12PUBLICATIONS
130CO-AUTHORS
Respiratory diseasesPharmacogenomicsMolecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 28, 2026
HCT-FS-Defined Frailty Is Associated With Lower Survival Across Diverse Hematologic Diagnoses After Allogeneic Transplantation.

|Oct 13, 2026
VERIFY: A Phase III Trial of Rusfertide Versus Placebo in Phlebotomy-Dependent Patients With Polycythemia Vera Receiving Standard-of-Care Therapy.

|Oct 08, 2026
Roginolisib in Combination with JAK Inhibitors in Patients with Myelofibrosis Who are Unresponsive to Approved JAK Inhibitors (Study HEMA-MED) - A Trial in Progress.

|Oct 17, 2025
Coexisting Myeloproliferative and Lymphoid Neoplasms: A European Multicenter Retrospective Study.

Dolly Viviana Fiallo-Suárez, Ruth Stuckey, Cristina Bilbao-Sieyro

|Jun 24, 2024
Post-transplant cyclophosphamide compared to sirolimus/tacrolimus in reduced intensity conditioning transplants for patients with lymphoid malignancies.

Maria Laura Fox, Irene García-Cadenas, Victor Navarro

|May 14, 2022
Impact of Individual Comorbidities on Survival of Patients with Myelofibrosis.

María García-Fortes, Juan C Hernández-Boluda, Alberto Álvarez-Larrán

Pageof 2

Frequent Collaborators

4 joint publications

Albert Esquirol

4 joint publications

Juan Carlos Hernandez-Boluda

3 joint publications

Alessandro Vannucchi

2 joint publications

Irene García-Cadenas